Exclusive Interview: Julian Bahr, Postdoctoral Fellow at AstraZeneca and speaker at 3D Cell Culture Conference Read more
Novartis investigational oral therapy iptacopan (LNP023) receives FDA Breakthrough Therapy Designation for PNH and Rare Pediatric Disease Designation for C3G Read more
Genosity Enters Into an Agreement With Gemini Therapeutics to Develop a Diagnostic and Implement Testing to Support Gemini’s Age-Related Macular Degeneration Trial Read more
Novartis announces positive FDA Advisory Committee recommendation for use of Entresto to treat patients with HFpEF Read more
ADC Therapeutics and Overland Pharma Form Strategic JV to Expand ADC Drugs Development and commercialization in Greater China and Singapore, Advised by MSQ Ventures Read more
Gavi, the Vaccine Alliance, Collaborates with Salesforce to Help Equitably Distribute Two Billion COVID-19 Vaccines by the End of 2021 Read more
Novartis reports positive topline results from second Phase III trial of Beovu in patients with diabetic macular edema Read more
Eureka Therapeutics Announces Successful Preclinical Results of InvisiMask™ Human Antibody Nasal Spray Against SARS-CoV-2 Infection Read more